Analysts think PTCT stock price could increase by 40%
Mar 08, 2026, 11:25 AM
6.76%
What does PTCT do
PTC Therapeutics, headquartered in Warren, New Jersey, develops medicines for rare disorders and has two key products for Duchenne muscular dystrophy. The company went public in 2013 and employs 988 people.
17 analysts think PTCT stock price will increase by 39.55%. The current median analyst target is $87.72 compared to a current stock price of $62.86. The lowest analysts target is $60.60 and the highest analyst target is $130.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.